(Q38984711)

8 September 2017

DNA sequencing and CRISPR-Cas9 gene editing for target validation in mammalian cells (English)

1 reference

8 September 2017

0 references

0 references

1 reference

Yegor Smurnyy

1

1 reference

8 September 2017

Mi Cai

2

1 reference

8 September 2017

Hua Wu

3

1 reference

8 September 2017

Elizabeth McWhinnie

4

1 reference

8 September 2017

John A Tallarico

5

1 reference

8 September 2017

Yi Yang

6

1 reference

8 September 2017

Yan Feng

7

1 reference

8 September 2017

15 June 2014

1 reference

8 September 2017

Nature Chemical Biology

1 reference

8 September 2017

10

1 reference

8 September 2017

623-625

1 reference

8 September 2017

8

1 reference

https://scigraph.springernature.com/pub.10.1038/nchembio.1550

8 September 2017

0 references

cites work

Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in Yeast

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.1550

Using transcriptome sequencing to identify mechanisms of drug action and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.1550

A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.1550

RNA-guided human genome engineering via Cas9

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.1550

Genome engineering using the CRISPR-Cas9 system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.1550

High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.1550

Resistance to 6-thioguanine in mismatch repair-deficient human cancer cell lines correlates with an increase in induced mutations at the HPRT locus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.1550

A preclinical evaluation of Minnelide as a therapeutic agent against pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.1550

XPB, a subunit of TFIIH, is a target of the natural product triptolide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.1550

Triptolide directly inhibits dCTP pyrophosphatase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.1550

Triptolide is a traditional Chinese medicine-derived inhibitor of polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.1550

TAB1: a target of triptolide in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.1550

Distinct roles for the XPB/p52 and XPD/p44 subcomplexes of TFIIH in damaged DNA opening during nucleotide excision repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.1550

p52 Mediates XPB function within the transcription/repair factor TFIIH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.1550

Triptolide: An inhibitor of a disintegrin and metalloproteinase 10 (ADAM10) in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.1550

One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.1550

Highly efficient CRISPR/Cas9-mediated knock-in in zebrafish by homology-independent DNA repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.1550

Chemically defined conditions for human iPSC derivation and culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.1550

BatchPrimer3: a high throughput web application for PCR and sequencing primer design

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.1550

The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.1550

A framework for variation discovery and genotyping using next-generation DNA sequencing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.1550

Fast and accurate short read alignment with Burrows-Wheeler transform

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.1550

ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.1550

dbSNP: the NCBI database of genetic variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.1550

Optimization of scarless human stem cell genome editing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.1550

In vivo genome editing using a high-efficiency TALEN system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.1550

Obligate ligation-gated recombination (ObLiGaRe): custom-designed nuclease-mediated targeted integration through nonhomologous end joining

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.1550

KBM-7, a human myeloid leukemia cell line with double Philadelphia chromosomes lacking normal c-ABL and BCR transcripts.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24929529

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

High-frequency genome editing using ssDNA oligonucleotides with zinc-finger nucleases

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24929529

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NCHEMBIO.1550

1 reference

Dimensions Publication ID

8 September 2017

0 references

1 reference